Search by Drug Name or NDC

NDC 10019-0953-02 MESNA 100 mg/mL Details

MESNA 100 mg/mL

MESNA is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is MESNA.

MedlinePlus Drug Summary

Mesna is used to reduce the risk of hemorrhagic cystitis (a condition that causes inflammation of the bladder and can result in serious bleeding) in people who receive ifosfamide (a medication used for the treatment of cancer). Mesna is in a class of medications called cytoprotectants. It works by protecting against some of the harmful effects of certain chemotherapy medications.

Related Packages: 10019-0953-02
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mesna Injection

Product Information

NDC	10019-0953
Product ID	10019-953_9734a242-cbd5-4569-bb78-97d37769cbe7
Associated GPIs	21758050002010
GCN Sequence Number	023756
GCN Sequence Number Description	mesna VIAL 100 MG/ML INTRAVEN
HIC3	V1I
HIC3 Description	CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS
GCN	38955
HICL Sequence Number	003934
HICL Sequence Number Description	MESNA
Brand/Generic	Generic
Proprietary Name	MESNA
Proprietary Name Suffix	n/a
Non-Proprietary Name	MESNA
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	100
Active Ingredient Units	mg/mL
Substance Name	MESNA
Labeler Name	Baxter Healthcare Corporation
Pharmaceutical Class	Cytoprotective Agent [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA019884
Listing Certified Through	2024-12-31

Package

NDC 10019-0953-02 (10019095302)

Pricing Information	N/A
NDC Package Code	10019-953-02
Billing NDC	10019095302
Package	10 VIAL, MULTI-DOSE in 1 BOX (10019-953-02) / 10 mL in 1 VIAL, MULTI-DOSE (10019-953-62)
Marketing Start Date	1988-12-30
NDC Exclude Flag	N